This grant offers funding to support the discovery of new compounds aimed at preventing and treating disorders of the nervous system. Research areas include compound identification, design, synthesis, preclinical testing, hit-to-lead chemistry, lead optimization, and drug metabolism. Projects emphasizing novel approaches to identifying therapeutic agents are encouraged. The closing date for this grant is January 7, 2022.
Opportunity ID: 311842
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-19-147 |
| Funding Opportunity Title: | Drug Discovery For Nervous System Disorders (R01 Clinical Trials Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.242 — Mental Health Research Grants |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Jan 08, 2019 |
| Last Updated Date: | Jan 08, 2019 |
| Original Closing Date for Applications: | Jan 07, 2022 |
| Current Closing Date for Applications: | Jan 07, 2022 |
| Archive Date: | Feb 12, 2022 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | State governments For profit organizations other than small businesses Native American tribal governments (Federally recognized) Public housing authorities/Indian housing authorities Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Native American tribal organizations (other than Federally recognized tribal governments) City or township governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Special district governments County governments Private institutions of higher education Public and State controlled institutions of higher education Independent school districts Small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This Funding Opportunity Announcement (FOA) supports the discovery of novel compounds for the prevention and treatment of nervous system disorders. Through this FOA NIMH and NIA wish to stimulate research in: 1) Identification, design, synthesis, and preclinical testing of compounds of candidate therapeutics; 2) Initial hit-to-lead chemistry to improve activity of compounds against the target of interest; 3) Later stage lead optimization to improve efficacy and pharmacokinetics; and 4) Initial drug metabolism and pharmacokinetic (DMPK). Emphasis will be placed on projects that provide novel approaches for identifying potential therapeutic agents. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-19-147.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | Use for due dates on or before May 24, 2020 | PKG00247400 | Jan 16, 2019 | May 24, 2020 | View | |
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00259342 | Jan 16, 2019 | Jan 24, 2022 | View | |
| FORMS-G | Use for due dates on or after January 25, 2022 | PKG00269688 | Oct 28, 2021 | Jan 07, 2022 | View |
Package 1
Mandatory forms
311842 RR_SF424_2_0-2.0.pdf
311842 PHS398_CoverPageSupplement_4_0-4.0.pdf
311842 RR_OtherProjectInfo_1_4-1.4.pdf
311842 PerformanceSite_2_0-2.0.pdf
311842 RR_KeyPersonExpanded_2_0-2.0.pdf
311842 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
311842 RR_Budget_1_4-1.4.pdf
311842 RR_SubawardBudget30_1_4-1.4.pdf
311842 PHS398_ModularBudget_1_2-1.2.pdf
311842 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
311842 RR_SF424_2_0-2.0.pdf
311842 PHS398_CoverPageSupplement_5_0-5.0.pdf
311842 RR_OtherProjectInfo_1_4-1.4.pdf
311842 PerformanceSite_2_0-2.0.pdf
311842 RR_KeyPersonExpanded_2_0-2.0.pdf
311842 PHS398_ResearchPlan_4_0-4.0.pdf
311842 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
311842 RR_Budget_1_4-1.4.pdf
311842 RR_SubawardBudget30_1_4-1.4.pdf
311842 PHS398_ModularBudget_1_2-1.2.pdf
311842 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 3
Mandatory forms
311842 RR_SF424_5_0-5.0.pdf
311842 PHS398_CoverPageSupplement_5_0-5.0.pdf
311842 RR_OtherProjectInfo_1_4-1.4.pdf
311842 PerformanceSite_4_0-4.0.pdf
311842 RR_KeyPersonExpanded_4_0-4.0.pdf
311842 PHS398_ResearchPlan_4_0-4.0.pdf
311842 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
311842 RR_Budget_3_0-3.0.pdf
311842 RR_SubawardBudget30_3_0-3.0.pdf
311842 PHS398_ModularBudget_1_2-1.2.pdf
311842 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
